Adrian Gottschalk
Chief Executive Officer chez FOGHORN THERAPEUTICS INC.
Fortune : 3 M $ au 31/03/2024
Profil
Adrian Gottschalk is the President, Chief Executive Officer & Director at Foghorn Therapeutics, Inc. He was previously the SVP & Head-Neurodegeneration Therapeutic Area at Biogen, Inc. Mr. Gottschalk received his undergraduate degree from Texas A&M University in 1997, his graduate degree from Harvard Medical School in 2004, and his MBA from MIT Sloan School of Management in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/02/2024 | 511 704 ( 1,20% ) | 3 M $ | 31/03/2024 |
Postes actifs de Adrian Gottschalk
| Sociétés | Poste | Début |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Executive Officer | 01/05/2017 |
Anciens postes connus de Adrian Gottschalk
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2017 |
Formation de Adrian Gottschalk
| Texas A&M University | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
